Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2004-3-18
pubmed:abstractText
This study was designed to evaluate the cost-effectiveness of screening patients with a B-type natriuretic peptide (BNP) blood test to identify those with depressed left ventricular systolic function.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0735-1097
pubmed:author
pubmed:issnType
Print
pubmed:day
17
pubmed:volume
43
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1019-26
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:15028361-Aged, pubmed-meshheading:15028361-Aged, 80 and over, pubmed-meshheading:15028361-Cohort Studies, pubmed-meshheading:15028361-Cost-Benefit Analysis, pubmed-meshheading:15028361-Decision Support Techniques, pubmed-meshheading:15028361-Echocardiography, pubmed-meshheading:15028361-Female, pubmed-meshheading:15028361-Humans, pubmed-meshheading:15028361-Male, pubmed-meshheading:15028361-Mass Screening, pubmed-meshheading:15028361-Middle Aged, pubmed-meshheading:15028361-Natriuretic Peptide, Brain, pubmed-meshheading:15028361-Predictive Value of Tests, pubmed-meshheading:15028361-Prevalence, pubmed-meshheading:15028361-Quality-Adjusted Life Years, pubmed-meshheading:15028361-Randomized Controlled Trials as Topic, pubmed-meshheading:15028361-United States, pubmed-meshheading:15028361-Ventricular Dysfunction, Left
pubmed:year
2004
pubmed:articleTitle
Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction.
pubmed:affiliation
11C Cardiology, VA Palo Alto Health Care System, Palo Alto VAMC, 3801 Miranda Avenue, Palo Alto, CA 94034, USA. heiden@stanford.edu
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S.